Evidence map›Paper›PMID 30654434›Full record

ArticleAntioxidants (Basel, Switzerland)2019

Naphtali Savion, Samia Dahamshi, Milana Morein, Shlomo Kotev-Emeth

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Oxidative Stress in Genetic Cataract Formation.Antioxidants (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Experimental biology and medicine (Maywood, N.J.) · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Naphtali SavionGoldschleger Eye Research Institute and Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv 61390, Israel. eyeres@tauex.tau.ac.il.ORCID 0000-0001-8899-0624
Samia DahamshiGoldschleger Eye Research Institute and Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv 61390, Israel. sdahamshi@gmail.com.
Milana MoreinGoldschleger Eye Research Institute and Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv 61390, Israel. tormoz111@hotmail.com.
Shlomo Kotev-EmethGoldschleger Eye Research Institute and Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv 61390, Israel. kotevs@tauex.tau.ac.il.
Tel Aviv University · IL

Funding

Aya Baharav fund for glaucoma research and prevention, Sackler Faculty of Medicine, Tel-Aviv University 3581Claire and Amédée Maratier Institute for the Study of Blindness and Visual Disorders, Tel Aviv University 3511
6 · The paper itself

Abstract

The capacity of

Indexed as

antioxidantcataractoxidationRPES-Allylmercapro-N-Acetylcysteine

Identifiers

PMID30654434
PMCPMC6357052
OpenAlexW2910380927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.